Gene signatures and prognostic factors in endometrial cancer. A study with special focus on vascular invasion

Mannelqvist, Monica

Mannelqvist, Monica

Doctoral thesis

Åpne

Main thesis (2.231Mb)

Paper IV: Draft version (660.7Kb)

Permanent lenke

https://hdl.handle.net/1956/4836

Utgivelsesdato

2011-04-15

Metadata

Vis full innførsel

Samlinger

Department of Clinical Medicine [1393]

Består av

Paper I: Histopathology 54(2), Mannelqvist, M.; Stefansson, I.; Salvesen, H. B.; Akslen, L. A., Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma, pp. 174-183. Copyright 2009 The Authors, journal compilation 2009 Blackwell Publishing. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1111/j.1365-2559.2008.03201.x

Paper II: American Journal of Pathology 178(2), Mannelqvist, M.; Stefansson, I. M.; Bredholt, G.; Bø, T. H.; Øyan, A. M.; Jonassen, I.; Kalland, K-H.; Salvesen, H. B.; Akslen, L. A., Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer, pp. 861-871. Copyright 2011 American Society for Investigative Pathology. Published by Elsevier. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1016/j.ajpath.2010.10.040

Paper III: British Journal of Cancer 98(10), Engelsen, I. B.; Mannelqvist, M.; Stefansson, I. M.; Carter, S. L.; Beroukhim, R.; Øyan, A. M.; Otte, A. P.; Kalland, K. H.; Akslen, L. A.; Salvesen, H. B., Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma, pp. 1662- 1669. Copyright 2008 Cancer Research. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1038/sj.bjc.6604360

Paper IV: Mannelqvist, M.; Stefansson, I.; Salvesen, H. B.; Akselen, L. A., 2011, Lipocalin 2 expression is associated with aggressive features of endometrial cancer. Draft version.

Utgiver

The University of Bergen